View in EDS HTML Full Text PDF Full Text

JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.

Saved in:
Bibliographic Details
Title: JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
Authors: Pennel, Kathryn A. F.1 (AUTHOR) kathryn.pennel@glasgow.ac.uk, Hatthakarnkul, Phimmada1 (AUTHOR), Wood, Colin S.1,2 (AUTHOR), Lian, Guang-Yu1 (AUTHOR), Al-Badran, Sara S. F.1 (AUTHOR), Quinn, Jean A.1 (AUTHOR), Legrini, Assya1 (AUTHOR), Inthagard, Jitwadee1 (AUTHOR), Alexander, Peter G.2 (AUTHOR), van Wyk, Hester2 (AUTHOR), Kurniawan, Ahmad1 (AUTHOR), Hashmi, Umar1,3 (AUTHOR), Gillespie, Michael A.4 (AUTHOR), Mills, Megan4 (AUTHOR), Ammar, Aula1 (AUTHOR), Hay, Jennifer5 (AUTHOR), Andersen, Ditte6 (AUTHOR), Nixon, Colin4 (AUTHOR), Rebus, Selma1 (AUTHOR), Chang, David K.1,2 (AUTHOR)
Source: Journal of Experimental & Clinical Cancer Research (17569966). 3/1/2024, Vol. 43 Issue 1, p1-20. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17569966
DOI:10.1186/s13046-024-02958-4